These different lines of evidence suggest that Insm1 plays an important role as a tumour-suppressor gene for NfpNETs and that differences in its level of expression can direct β-cell transformation toward either a differentiated insulinoma or a metastatic and more aggressive nonfunctioning form. This evidence concerns the gene INSM1 and neoplasm.